Literature DB >> 16711314

Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose.

Fouad J Moawad1, Joshua D Hartzell, Timothy J Biega, Christopher J Lettieri.   

Abstract

Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencephalopathy syndrome (RPLS), is most often associated with hypertensive emergencies and is characterized by seizures, mental status changes and visual disturbances. We report a case of a previously healthy young man who developed multiorgan failure and transient cortical blindness following ingestion of a performance-enhancing ephedra-based supplement. Neuroimaging findings confirmed the clinical suspicion of PRES. Radiographic abnormalities and neurologic dysfunction subsequently resolved with correction of his systolic blood pressure. This case emphasizes the need for prompt treatment and consideration of toxic ingestions in patients presenting with hypertension-related end-organ dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16711314     DOI: 10.1097/01.smj.0000215739.90211.3b

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  [Acute bilateral loss of vision in posterior reversible encephalopathy syndrome].

Authors:  K S Bonsel; I Oberacher-Velten; K Hufendiek; H Jägle
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

2.  Hypertensive retinopathy associated with use of the ephedra-free weight-loss herbal supplement Hydroxycut.

Authors:  Scott L Willis; Fouad J Moawad; Joshua D Hartzell; Melissa Iglesias; William L Jackson
Journal:  MedGenMed       Date:  2006-09-28

3.  Malignant hypertension and acute aortic dissection associated with caffeine-based ephedra-free dietary supplements: a case report.

Authors:  Imdad Ahmed
Journal:  Cases J       Date:  2009-04-03

4.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Tacrolimus associated posterior reversible encephalopathy syndrome - a case series and review.

Authors:  Susmitha Apuri; Kristin Carlin; Edward Bass; Phuong Thuy Nguyen; John N Greene
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-18       Impact factor: 2.576

Review 6.  The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety.

Authors:  Martins Ekor
Journal:  Front Pharmacol       Date:  2014-01-10       Impact factor: 5.810

7.  Neuroprotective effect of gui zhi (ramulus cinnamomi) on ma huang- (herb ephedra-) induced toxicity in rats treated with a ma huang-gui zhi herb pair.

Authors:  Fang-Hao Zheng; Ping Wei; Hui-Ling Huo; Xue-Feng Xing; Fei-Long Chen; Xiao-Mei Tan; Jia-Bo Luo
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-26       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.